Page last updated: 2024-10-24

chlorambucil and Respiration Disorders

chlorambucil has been researched along with Respiration Disorders in 1 studies

Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.

Respiration Disorders: Diseases of the respiratory system in general or unspecified or for a specific respiratory disease not available.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
FURGERSON, WB1
BACHMAN, LB1
O'TOOLE, WF1

Other Studies

1 other study available for chlorambucil and Respiration Disorders

ArticleYear
WALDENSTROM'S MACROGLOBULINEMIA WITH DIFFUSE PULMONARY INFILTRATION: LUNG BIOPSY AND RESPONSE TO CHLORAMBUCIL THERAPY.
    The American review of respiratory disease, 1963, Volume: 88

    Topics: Biopsy; Blood Protein Electrophoresis; Chlorambucil; Humans; Lung Diseases; Radiography, Thoracic; R

1963